James J. Ferguson
About
James J. Ferguson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine.
According to data from OpenAlex, James J. Ferguson has authored 222 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Cardiology and Cardiovascular Medicine, 67 papers in Surgery and 46 papers in Internal Medicine. Recurrent topics in James J. Ferguson's work include Acute Myocardial Infarction Research (85 papers), Antiplatelet Therapy and Cardiovascular Diseases (51 papers) and Venous Thromboembolism Diagnosis and Management (46 papers). James J. Ferguson is often cited by papers focused on Acute Myocardial Infarction Research (85 papers), Antiplatelet Therapy and Cardiovascular Diseases (51 papers) and Venous Thromboembolism Diagnosis and Management (46 papers). James J. Ferguson collaborates with scholars based in United States, Canada and Australia. James J. Ferguson's co-authors include Marc Cohen, Eric J. Topol, Harry Rudney, Gregg W. Stone, Kenneth W. Mahaffey, Elliott M. Antman, Robert A. Harrington, Neal S. Kleiman, Robert J. Freedman and H. Vernon Anderson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
James J. Ferguson
214 papers receiving 5.8k citations
Peers
James J. Ferguson
Paolo Golino Italy
Michael R. Buchanan Canada
Gemma Vilahur Spain
Teresa Padró Spain
H. Sinzinger Austria
Bianca Rocca Italy
Keijiro Saku Japan
Hitoshi Hishida Japan
Cristina Chimenti Italy
Akio Kawamura Japan
Citations per year, relative to James J. Ferguson James J. Ferguson (= 1×)
peers
Paolo Golino
Countries citing papers authored by James J. Ferguson
Since
Specialization
Citations
This map shows the geographic impact of James J. Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Ferguson more than expected).
Fields of papers citing papers by James J. Ferguson
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by James J. Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Ferguson. The network helps show where James J. Ferguson may publish in the future.
Co-authorship network of co-authors of James J. Ferguson
This figure shows the co-authorship network connecting the top 25 collaborators of James J. Ferguson. A scholar is included among the top collaborators of James J. Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. Ferguson. James J. Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ferguson, James J., Bala Rathinasabapathi, & Carlene A. Chase. (2013). Allelopathy: How Plants Suppress Other Plants. SHILAP Revista de lepidopterología. 2013(3).
2.
Aronow, Herbert D., Robert M. Califf, Robert A. Harrington, et al.. (2008). Relation Between Aspirin Dose, All-Cause Mortality, and Bleeding in Patients With Recent Cerebrovascular or Coronary Ischemic Events (from the BRAVO Trial). The American Journal of Cardiology. 102(10). 1285–1290.
3.
Scholberg, Johannes, et al.. (2008). Use of the Cover Crop Weed Index to Evaluate Weed Suppression by Cover Crops in Organic Citrus Orchards. HortScience. 43(1). 27–34.
4.
Cohen, Marc, Glenn N. Levine, James J. Ferguson, et al.. (2007). Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.. PubMed. 19(12). 525–38; quiz 539.
5.
Stone, Gregg W., Robert M. Clare, Kenneth W. Mahaffey, et al.. (2006). Impact of enoxaparin on thrombus formation, coronary blood flow, and myocardial perfusion after early invasive treatment during acute coronary syndrome: Results from the SYNERGY library. Circulation. 114(18). 600–600.
6.
Ohman, E. Magnus, Michael F. Miller, Debra L. Joseph, et al.. (2003). Validation of a Multicenter Registry Database of Intra-Aortic Balloon Pumping in a Variety of Clinical Settings. 3(1). 8–13.
7.
Scirica, Benjamin M., Christopher P. Cannon, C. Michael Gibson, et al.. (2002). Assessing the Effect of Publication of Clinical Guidelines on the Management of Unstable Angina and Non-ST Elevation Myocardial Infarction in The TIMI III (1990???1993) and the GUARANTEE (1995???1996) Registries. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 1(3). 150–158.
8.
Scirica, Benjamin M., Christopher P. Cannon, Michael C. Gibson, et al.. (2002). Assessing the Effect of Publication of Clinical Guidelines on the Management of Unstable Angina and Non-ST Elevation Myocardial Infarction in The TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 1(3). 150–158.
9.
Ferguson, James J.. (2002). Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-st-elevation myocardial infarction. Clinical Cardiology. 25(S1). 16–22.
10.
Anderson, Keaven M., Robert M. Califf, Gregg W. Stone, et al.. (2001). Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. Journal of the American College of Cardiology. 37(8). 2059–2065.
11.
Topol, Eric J., James J. Ferguson, Harlan F. Weisman, et al.. (1998). Long-Term Protection from Myocardial Ischemic Events in a Randomized Trial of Brief Integrin ??3 Blockade with Percutaneous Coronary Intervention. Survey of Anesthesiology. 42(4). 194???195–194???195.
12.
Lincoff, A. Michael, James E. Tcheng, Robert M. Califf, et al.. (1997). Standard Versus Low-Dose Weight-Adjusted Heparin in Patients Treated With the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3 Fab) During Percutaneous Coronary Revascularization. The American Journal of Cardiology. 79(3). 286–291.
13.
Aguirre, Frank V., James J. Ferguson, James C. Blankenship, et al.. (1996). Association of pre-intervention activated clotting times (ACT) and clinical outcomes following percutaneous coronary revascularization: Results from the IMPACT-II trial. Journal of the American College of Cardiology. 27(2). 83–83.
14.
Bittl, John A., Mark W. Wolfe, Gary S. Roubin, et al.. (1995). 1017-74 Length of Hospital Stay After Percutaneous Transluminal Coronary Angioplasty: Clinical and Angiographic Predictors. Journal of the American College of Cardiology. 25(2). 392A–392A.
15.
Ferguson, James J., et al.. (1994). Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty. Journal of the American College of Cardiology. 23(4). 907–910.
16.
Ferguson, James J., et al.. (1991). Efficacy of multiple balloon aortic valvuloplasty procedures. Journal of the American College of Cardiology. 17(6). 1430–1435.
17.
Spears, J. Richard, Vincent P. Reyes, H.W. Thijs Plokker, et al.. (1990). Laser balloon angioplasty: Coronary angiografhic follow-up of a multicenter trial. Journal of the American College of Cardiology. 15(2). A26–A26.
18.
Ferguson, James J., et al.. (1989). Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction. The American Journal of Cardiology. 64(5). 311–314.
19.
McKay, Raymond G., Michael Miller, James J. Ferguson, et al.. (1986). Assessment of left ventricular end-systolic pressure-volume relations with an impedance catheter and transient inferior vena cava occlusion: Use of this system in the evaluation of the cardiotonic effects of dobutamine, milrinone, posicor and epinephrine. Journal of the American College of Cardiology. 8(5). 1152–1160.
20.
Ferguson, James J. & Bala Rathinasabapathi. (1969). Allelopathy: How Plants Suppress Other Plants. SHILAP Revista de lepidopterología. 2003(18).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Paolo Golino Breakdown of academic impact, for papers by Michael R. Buchanan Breakdown of academic impact, for papers by Gemma Vilahur Breakdown of academic impact, for papers by Teresa Padró Breakdown of academic impact, for papers by H. Sinzinger Breakdown of academic impact, for papers by Bianca Rocca Breakdown of academic impact, for papers by Keijiro Saku Breakdown of academic impact, for papers by Hitoshi Hishida Breakdown of academic impact, for papers by Cristina Chimenti Breakdown of academic impact, for papers by Akio Kawamura